China Meheco Group Co., Ltd. (SHA:600056)
10.40
-0.14 (-1.33%)
May 22, 2025, 2:45 PM CST
China Meheco Group Revenue
China Meheco Group had revenue of 8.26B CNY in the quarter ending March 31, 2025, a decrease of -5.84%. This brings the company's revenue in the last twelve months to 33.64B, down -4.08% year-over-year. In the year 2024, China Meheco Group had annual revenue of 34.15B, down -12.04%.
Revenue (ttm)
33.64B
Revenue Growth
-4.08%
P/S Ratio
0.46
Revenue / Employee
4.02M
Employees
8,368
Market Cap
15.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34.15B | -4.68B | -12.04% |
Dec 31, 2023 | 38.82B | 1.23B | 3.28% |
Dec 31, 2022 | 37.59B | 1.36B | 3.75% |
Dec 31, 2021 | 36.23B | -3.08B | -7.83% |
Dec 31, 2020 | 39.31B | 4.03B | 11.41% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |